Shedding light on the structure of silver nanoparticles with promising properties for nano-oncology; Journal of Nanoparticle Research; Vol. 27, iss. 9

מידע ביבליוגרפי
Parent link:Journal of Nanoparticle Research.— .— New York: Springer Science+Business Media LLC
Vol. 27, iss. 9.— 2025.— Article number 238, 11 p.
מחברים אחרים: Serrato-Barragan J. A. Jesus, Casillas-Figueroa F. Francisco, Luna-Vazquez-Gomez R. Roberto, Ruiz-Ruiz B. Balam, Garibo-Ruiz D., Rodriguez-Hernandez A. G. Ana, Pestryakov A. N. Aleksey Nikolaevich, Bogdanchikova N. Nina
סיכום:Title screen
Nowadays, nanomedicine has been a highly explored area for finding potential solutions to global public health problems. In nanomedicine, silver nanoparticles are the most studied nanoparticles due to their excellent antibacterial, fungicidal, antiviral, and anticancer properties. Recently, our research group has revealed some extraordinary properties that significantly impact nano-cancerology for specific commercial ArgovitTM AgNP formulations. It was shown that they (1) are 2 to 200 times (on average 52 times) more active than the other 16 AgNP formulations studied earlier in inhibiting the growth of 7 cancer cell lines, and (2) they selectively inhibit the growth of cancer cells with the selectivity index reaching 16. Results of the present work obtained with HRTEM, DLS, UV-visible spectroscopy, and electrophoresis indicate that the structure of AgNP of the ArgovitTM formulation family is atypical, which cannot be explained from the point of view of the structure of usual AgNPs (Ag cores surrounded by stabilizer molecules). It was hypothesized that these matrices can be represented by nano- and microgels formed by the stabilizer. The formation of these atypical structures can cause their remarkable biomedical properties, which are highly desirable for nano-oncology. These results represent the first step towards shedding light on the structure of AgNPs of the ArgovitTM formulation family
Текстовый файл
AM_Agreement
שפה:אנגלית
יצא לאור: 2025
נושאים:
גישה מקוונת:https://doi.org/10.1007/s11051-025-06436-6
פורמט: אלקטרוני Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=682254

MARC

LEADER 00000naa0a2200000 4500
001 682254
005 20251014093908.0
090 |a 682254 
100 |a 20251014a2025 k||y0rusy50 ba 
101 0 |a eng 
102 |a US 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Shedding light on the structure of silver nanoparticles with promising properties for nano-oncology  |f Jesus A. Serrato-Barragan, Francisco Casillas-Figueroa, Roberto Luna-Vázquez-Gomez [et al.] 
203 |a Текст  |c электронный  |b визуальный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 18 tit 
330 |a Nowadays, nanomedicine has been a highly explored area for finding potential solutions to global public health problems. In nanomedicine, silver nanoparticles are the most studied nanoparticles due to their excellent antibacterial, fungicidal, antiviral, and anticancer properties. Recently, our research group has revealed some extraordinary properties that significantly impact nano-cancerology for specific commercial ArgovitTM AgNP formulations. It was shown that they (1) are 2 to 200 times (on average 52 times) more active than the other 16 AgNP formulations studied earlier in inhibiting the growth of 7 cancer cell lines, and (2) they selectively inhibit the growth of cancer cells with the selectivity index reaching 16. Results of the present work obtained with HRTEM, DLS, UV-visible spectroscopy, and electrophoresis indicate that the structure of AgNP of the ArgovitTM formulation family is atypical, which cannot be explained from the point of view of the structure of usual AgNPs (Ag cores surrounded by stabilizer molecules). It was hypothesized that these matrices can be represented by nano- and microgels formed by the stabilizer. The formation of these atypical structures can cause their remarkable biomedical properties, which are highly desirable for nano-oncology. These results represent the first step towards shedding light on the structure of AgNPs of the ArgovitTM formulation family 
336 |a Текстовый файл 
371 0 |a AM_Agreement 
461 1 |t Journal of Nanoparticle Research  |c New York  |n Springer Science+Business Media LLC 
463 1 |t Vol. 27, iss. 9  |v Article number 238, 11 p.  |d 2025 
610 1 |a Silver nanoparticles 
610 1 |a Structure 
610 1 |a Nano and micro gel 
610 1 |a Promising for nano-oncology 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
701 1 |a Serrato-Barragan  |b J. A.  |g Jesus 
701 1 |a Casillas-Figueroa  |b F.  |g Francisco 
701 1 |a Luna-Vazquez-Gomez  |b R.  |g Roberto 
701 1 |a Ruiz-Ruiz  |b B.  |g Balam 
701 1 |a Garibo-Ruiz  |b D. 
701 1 |a Rodriguez-Hernandez  |b A. G.  |g Ana 
701 1 |a Pestryakov  |b A. N.  |c Chemist  |c Professor of Tomsk Polytechnic University, Doctor of Chemical Science  |f 1963-  |g Aleksey Nikolaevich  |9 14796 
701 1 |a Bogdanchikova  |b N.  |g Nina 
801 0 |a RU  |b 63413507  |c 20251014  |g RCR 
856 4 |u https://doi.org/10.1007/s11051-025-06436-6  |z https://doi.org/10.1007/s11051-025-06436-6 
942 |c CF